Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: An immunohistochemical profile of 44 cases

Timothy D. Jones, Kevin M. Kernek, Ximing J. Yang, Antonio Lopez-Beltran, Gregory T. MacLennan, John Eble, Haiqun Lin, Chong Xian Pan, Maria Tretiakova, Lee Ann Baldridge, Liang Cheng

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Small cell carcinoma of the urinary bladder is a rare and aggressive tumor resembling small cell carcinoma of the lung. Thyroid transcription factor 1 (TTF-1) expression is common in small cell carcinomas arising in the lung. However, studies of its expression in extrapulmonary small cell carcinomas have yielded varying results. Because information concerning the immunohistochemical profile of small cell carcinoma of the urinary bladder is limited, we investigated the immunoreactivity of this tumor to a battery of antibodies in a series of 44 cases. Using 5-μm sections cut from paraffin-embedded tissue blocks, immunohistochemistry was performed to detect TTF-1, cytokeratin (CK) 7, CK20, and uroplakin antigenicity in 44 cases of small cell carcinoma of the urinary bladder. None of the patients had primary lung tumors. The TTF-1 immunohistochemical stain showed nuclear positivity in 17 cases (39%). Positive immunostaining for CK7 was observed in 26 cases (59%). There was no positive staining with either CK20 or uroplakin. There was no correlation between TTF-1 expression and survival (P = .27). In addition, TTF-1 expression did not correlate with clinicopathological characteristics, including age (P = .74), sex (P = .53), smoking history (P = .96), clinical stage (P = .10), pathological T stage (P = .50), lymph node metastasis (P = .40), and distant metastasis (P = .58). In summary, TTF-1 expression in small cell carcinoma of the urinary bladder was found in 39% of the tumors, demonstrating that this marker is expressed in small cell carcinomas other than those of pulmonary origin. Small cell carcinoma of the urinary bladder is positive for CK7 immunostaining in 59% of cases consistent with its origin from urothelium. Unlike urothelial carcinoma, expression of CK20 and uroplakin in small cell carcinoma of the urinary bladder is consistently negative, and thus, these stains do not appear to be useful in the diagnosis of this neoplasm. TTF-1 positivity is not a significant prognostic factor in small cell carcinoma of the urinary bladder.

Original languageEnglish
Pages (from-to)718-723
Number of pages6
JournalHuman Pathology
Volume36
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Small Cell Carcinoma
Urinary Bladder
Uroplakins
Lung
Neoplasms
Coloring Agents
thyroid nuclear factor 1
Keratin-7
Neoplasm Metastasis
Urothelium
Small Cell Lung Carcinoma
Tumor Biomarkers
Paraffin
Lymph Nodes
Smoking
History
Immunohistochemistry
Staining and Labeling
Carcinoma

Keywords

  • Cytokeratin 20
  • Cytokeratin 7
  • Immunohistochemistry
  • Neoplasm
  • Small cell carcinoma
  • TTF-1
  • Urinary bladder
  • Uroplakin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder : An immunohistochemical profile of 44 cases. / Jones, Timothy D.; Kernek, Kevin M.; Yang, Ximing J.; Lopez-Beltran, Antonio; MacLennan, Gregory T.; Eble, John; Lin, Haiqun; Pan, Chong Xian; Tretiakova, Maria; Baldridge, Lee Ann; Cheng, Liang.

In: Human Pathology, Vol. 36, No. 7, 07.2005, p. 718-723.

Research output: Contribution to journalArticle

Jones, TD, Kernek, KM, Yang, XJ, Lopez-Beltran, A, MacLennan, GT, Eble, J, Lin, H, Pan, CX, Tretiakova, M, Baldridge, LA & Cheng, L 2005, 'Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: An immunohistochemical profile of 44 cases', Human Pathology, vol. 36, no. 7, pp. 718-723. https://doi.org/10.1016/j.humpath.2005.04.007
Jones, Timothy D. ; Kernek, Kevin M. ; Yang, Ximing J. ; Lopez-Beltran, Antonio ; MacLennan, Gregory T. ; Eble, John ; Lin, Haiqun ; Pan, Chong Xian ; Tretiakova, Maria ; Baldridge, Lee Ann ; Cheng, Liang. / Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder : An immunohistochemical profile of 44 cases. In: Human Pathology. 2005 ; Vol. 36, No. 7. pp. 718-723.
@article{683b933e958b49acaa13803ad770982d,
title = "Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: An immunohistochemical profile of 44 cases",
abstract = "Small cell carcinoma of the urinary bladder is a rare and aggressive tumor resembling small cell carcinoma of the lung. Thyroid transcription factor 1 (TTF-1) expression is common in small cell carcinomas arising in the lung. However, studies of its expression in extrapulmonary small cell carcinomas have yielded varying results. Because information concerning the immunohistochemical profile of small cell carcinoma of the urinary bladder is limited, we investigated the immunoreactivity of this tumor to a battery of antibodies in a series of 44 cases. Using 5-μm sections cut from paraffin-embedded tissue blocks, immunohistochemistry was performed to detect TTF-1, cytokeratin (CK) 7, CK20, and uroplakin antigenicity in 44 cases of small cell carcinoma of the urinary bladder. None of the patients had primary lung tumors. The TTF-1 immunohistochemical stain showed nuclear positivity in 17 cases (39{\%}). Positive immunostaining for CK7 was observed in 26 cases (59{\%}). There was no positive staining with either CK20 or uroplakin. There was no correlation between TTF-1 expression and survival (P = .27). In addition, TTF-1 expression did not correlate with clinicopathological characteristics, including age (P = .74), sex (P = .53), smoking history (P = .96), clinical stage (P = .10), pathological T stage (P = .50), lymph node metastasis (P = .40), and distant metastasis (P = .58). In summary, TTF-1 expression in small cell carcinoma of the urinary bladder was found in 39{\%} of the tumors, demonstrating that this marker is expressed in small cell carcinomas other than those of pulmonary origin. Small cell carcinoma of the urinary bladder is positive for CK7 immunostaining in 59{\%} of cases consistent with its origin from urothelium. Unlike urothelial carcinoma, expression of CK20 and uroplakin in small cell carcinoma of the urinary bladder is consistently negative, and thus, these stains do not appear to be useful in the diagnosis of this neoplasm. TTF-1 positivity is not a significant prognostic factor in small cell carcinoma of the urinary bladder.",
keywords = "Cytokeratin 20, Cytokeratin 7, Immunohistochemistry, Neoplasm, Small cell carcinoma, TTF-1, Urinary bladder, Uroplakin",
author = "Jones, {Timothy D.} and Kernek, {Kevin M.} and Yang, {Ximing J.} and Antonio Lopez-Beltran and MacLennan, {Gregory T.} and John Eble and Haiqun Lin and Pan, {Chong Xian} and Maria Tretiakova and Baldridge, {Lee Ann} and Liang Cheng",
year = "2005",
month = "7",
doi = "10.1016/j.humpath.2005.04.007",
language = "English",
volume = "36",
pages = "718--723",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder

T2 - An immunohistochemical profile of 44 cases

AU - Jones, Timothy D.

AU - Kernek, Kevin M.

AU - Yang, Ximing J.

AU - Lopez-Beltran, Antonio

AU - MacLennan, Gregory T.

AU - Eble, John

AU - Lin, Haiqun

AU - Pan, Chong Xian

AU - Tretiakova, Maria

AU - Baldridge, Lee Ann

AU - Cheng, Liang

PY - 2005/7

Y1 - 2005/7

N2 - Small cell carcinoma of the urinary bladder is a rare and aggressive tumor resembling small cell carcinoma of the lung. Thyroid transcription factor 1 (TTF-1) expression is common in small cell carcinomas arising in the lung. However, studies of its expression in extrapulmonary small cell carcinomas have yielded varying results. Because information concerning the immunohistochemical profile of small cell carcinoma of the urinary bladder is limited, we investigated the immunoreactivity of this tumor to a battery of antibodies in a series of 44 cases. Using 5-μm sections cut from paraffin-embedded tissue blocks, immunohistochemistry was performed to detect TTF-1, cytokeratin (CK) 7, CK20, and uroplakin antigenicity in 44 cases of small cell carcinoma of the urinary bladder. None of the patients had primary lung tumors. The TTF-1 immunohistochemical stain showed nuclear positivity in 17 cases (39%). Positive immunostaining for CK7 was observed in 26 cases (59%). There was no positive staining with either CK20 or uroplakin. There was no correlation between TTF-1 expression and survival (P = .27). In addition, TTF-1 expression did not correlate with clinicopathological characteristics, including age (P = .74), sex (P = .53), smoking history (P = .96), clinical stage (P = .10), pathological T stage (P = .50), lymph node metastasis (P = .40), and distant metastasis (P = .58). In summary, TTF-1 expression in small cell carcinoma of the urinary bladder was found in 39% of the tumors, demonstrating that this marker is expressed in small cell carcinomas other than those of pulmonary origin. Small cell carcinoma of the urinary bladder is positive for CK7 immunostaining in 59% of cases consistent with its origin from urothelium. Unlike urothelial carcinoma, expression of CK20 and uroplakin in small cell carcinoma of the urinary bladder is consistently negative, and thus, these stains do not appear to be useful in the diagnosis of this neoplasm. TTF-1 positivity is not a significant prognostic factor in small cell carcinoma of the urinary bladder.

AB - Small cell carcinoma of the urinary bladder is a rare and aggressive tumor resembling small cell carcinoma of the lung. Thyroid transcription factor 1 (TTF-1) expression is common in small cell carcinomas arising in the lung. However, studies of its expression in extrapulmonary small cell carcinomas have yielded varying results. Because information concerning the immunohistochemical profile of small cell carcinoma of the urinary bladder is limited, we investigated the immunoreactivity of this tumor to a battery of antibodies in a series of 44 cases. Using 5-μm sections cut from paraffin-embedded tissue blocks, immunohistochemistry was performed to detect TTF-1, cytokeratin (CK) 7, CK20, and uroplakin antigenicity in 44 cases of small cell carcinoma of the urinary bladder. None of the patients had primary lung tumors. The TTF-1 immunohistochemical stain showed nuclear positivity in 17 cases (39%). Positive immunostaining for CK7 was observed in 26 cases (59%). There was no positive staining with either CK20 or uroplakin. There was no correlation between TTF-1 expression and survival (P = .27). In addition, TTF-1 expression did not correlate with clinicopathological characteristics, including age (P = .74), sex (P = .53), smoking history (P = .96), clinical stage (P = .10), pathological T stage (P = .50), lymph node metastasis (P = .40), and distant metastasis (P = .58). In summary, TTF-1 expression in small cell carcinoma of the urinary bladder was found in 39% of the tumors, demonstrating that this marker is expressed in small cell carcinomas other than those of pulmonary origin. Small cell carcinoma of the urinary bladder is positive for CK7 immunostaining in 59% of cases consistent with its origin from urothelium. Unlike urothelial carcinoma, expression of CK20 and uroplakin in small cell carcinoma of the urinary bladder is consistently negative, and thus, these stains do not appear to be useful in the diagnosis of this neoplasm. TTF-1 positivity is not a significant prognostic factor in small cell carcinoma of the urinary bladder.

KW - Cytokeratin 20

KW - Cytokeratin 7

KW - Immunohistochemistry

KW - Neoplasm

KW - Small cell carcinoma

KW - TTF-1

KW - Urinary bladder

KW - Uroplakin

UR - http://www.scopus.com/inward/record.url?scp=23444443878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444443878&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2005.04.007

DO - 10.1016/j.humpath.2005.04.007

M3 - Article

C2 - 16084939

AN - SCOPUS:23444443878

VL - 36

SP - 718

EP - 723

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 7

ER -